表紙
市場調查報告書

神經功能替代 (人工神經)的全球市場:市場分析、佔有率、趨勢、規模、預測

Neuroprosthetics Market, By Types (Cochlear Implants, Motor Prosthetics, Cognitive Prosthetics, and Retinal Implants), By Technology (VNS, SCS, DBS, and SNS), By Application, and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

出版商 AnalystView Market Insights 商品編碼 737918
出版日期 內容資訊 英文 106 Pages
商品交期: 2-3個工作天內
價格
神經功能替代 (人工神經)的全球市場:市場分析、佔有率、趨勢、規模、預測 Neuroprosthetics Market, By Types (Cochlear Implants, Motor Prosthetics, Cognitive Prosthetics, and Retinal Implants), By Technology (VNS, SCS, DBS, and SNS), By Application, and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
出版日期: 2018年01月04日內容資訊: 英文 106 Pages
簡介

本報告提供全球神經功能替代 (人工神經,神經補綴)的市場相關分析,市場定義和基本結構,主要的推動及阻礙市場要素,產業的競爭力、向心力,市場佔有率結構,各類型、各技術、各用途、各地區的市場趨勢預測 (過去4年、今後8年份),主要企業的簡介等相關調查。

第1章 神經功能替代市場:概要

第2章 摘要整理

第3章 神經功能替代市場:主要趨勢

  • 推動市場要素
    • 促進因素的影響度
  • 阻礙市場要素
    • 阻礙因素的影響度
  • 市場機會
  • 市場未來趨勢

第4章 神經功能替代產業分析

  • 波特的五力分析
  • 市場向心力分析
  • 管理體制分析

第5章 神經功能替代的市場環境

  • 市場佔有率分析

第6章 神經功能替代市場:各類型

  • 概要
  • 人工電子耳
    • 概要
    • 市場規模分析、預測,年度成長率 (以金額為準,總計12年份)
  • 運動補綴
  • 認識補綴
  • 視網膜移植

第7章 神經功能替代市場:各技術

  • 概要
  • 迷走神經刺激 (VNS)
  • 脊髓刺激 (SCN)
  • 腦深部刺激 (DBS)
  • 薦椎神經刺激 (SNS)

第8章 神經功能替代市場:各用途

  • 概要
  • 生理障礙
    • 聽覺障礙
    • 腎臟障礙
    • 其他
  • 運動神經障礙
    • 癲癇
    • 帕金森氏症
  • 認知障礙
    • 阿茲海默症
    • 重度抑憂鬱症

第9章 神經功能替代市場:各地區

  • 簡介
  • 北美 (美國,加拿大)
    • 概要
    • 市場規模分析、預測,年度成長率 (以金額為準,總計12年份)
    • 各國分析
  • 歐洲 (法國,德國等)
  • 亞太地區 (中國,印度等)
  • 其他的國家 (RoW:南美,中東、非洲)

第10章 主要供應商分析

  • Cochlear Limited
    • 企業概要
    • SWOT分析
    • 近幾年的主要趨勢
  • St. Jude Medical, Inc.
  • Medtronic, Inc.
  • Nervo Corporation
  • MED-EL

第10章 分析師的全方位的分析

第11章 附錄

目錄
Product Code: AV152

Report Hightlights

The neuroprosthetics market is estimated to represent a global market of USD 4,763 million by 2017 with growth rate of 4.5%.

Neuroprosthetic is a medical device, designed to supplement the input or output of a nervous system. These devices are linked to the central nervous system and translate electrical neural activity from the brain into control signals in order to control artificial limbs or to enable to restore lost sensory function. Neuroprosthetics are featured to enhance motor, sensory, and cognitive ability of an organism. Many research studies suggest that neuroprosthetics significantly improve the quality of life of patients suffering from motor disorders such as amputation and paralysis.

Market Dynamics

Continuous rising prevalence of neurological diseases, such as epilepsy, Parkinson's disease, tremor, and dystonia, is considered to be a high-impact rendering driver for the neuroprosthetics market. According to the WHO, neurological diseases constitutes 6.3% of the global chronic disease burden and are one of the key causes of mortality globally, to result in 13.2% deaths in developed countries as well as 16.8% in low- and middle-income countries. Furthermore, Technological advancements in neuroprosthetics are anticipated to create growth opportunities for this market. For instance, in September 2017, MED-EL announced the launch of RONDO 2, a cochlear implant audio processor that can be charged wirelessly thereby improving the use of these implants among patients. Other notable advancements include the emergence of robot-assisted implantation, a microelectrode, multi-target stimulation, and integrated implantable pulse generators. However, high cost associated with neuroprosthetics is the critical restraining factor for the overall industry growth.

Types Takeaway

In terms of types, the market is divided into Cochlear Implants, Motor Prosthetics, Cognitive Prosthetics, and Retinal Implants. Motor Prosthetics is accounted for the 43.25%, the largest share of the total market in 2017. These prosthetics are also known as Brain Machine Interface (BMI), which help in restoring motor functions in patients with neurological disorders. Rising number of research activities with respect to the neural motor prosthesis is anticipated to offer strong growth of this segment. Based on technology, the market is broadly bifurcated into Vagus Nerve Stimulation, Spinal Cord Stimulation, Deep Brain Simulation, and Sacral Nerve Stimulation. Technologies such as DBS and SNS are growing rapidly and are expected to capture the significant share of the global market over the future period.

Application Takeaway

Application section is distributed as Physiological Disorders, Motor Neuron Disorders, and Cognitive Disorders. Physiological disorders segment is further divided into Auditory Disorders, Kidney Disorders, and others. The largest application segment, motor neuron disorders are divided in terms of Epilepsy, and Parkinson's disease. Cognitive Disorders is categorized as Alzheimer's disease and Severe Depression. Among which, neuroprosthetics are widely used for the treatment of Parkinson's disease. During the year 2017, this segment captured almost 70% share of the motor neuron disorders market. Prevalence/incidence of this disease is constantly increasing across the world. According to Parkinson's News Today, around 60,000 people in the U.S. are diagnosed with Parkinson's disease every year.

Regional Takeaway

Regionally, North America recorded the largest share of the total market due to the rising research and development activities. Europe followed North America, backed by the increasing incidences of neurological disorders and rise in product demand. Developing regions such as the Asia Pacific and Latin America is considered to grow with the highest growth rate over the future period owing to the favorable government initiatives coupled with the rising awareness level.

Key Vendor Takeaway

Key players such as Cochlear Limited, St. Jude Medical, Inc., Medtronic, Inc., Nervo Corporation and MED-EL are profiled under the report scope. Product approvals, strategic collaborations, and new product launches are some of the sustainable strategies adopted by the companies operating in this market. Medtronic notched significant revenue share of the global market in 2016 owing to the extensive product line and strong strategies to expand in the market. For instance, in November 2017, Medtronic's Intellis ? platform received the CE Mark for both spinal cord stimulation and peripheral nerve stimulation in the management of chronic pain thereby expanding its product portfolio.

TABLE OF CONTENTS

1. NEUROPROSTHETICS MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Base Year
  • 1.3. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Key Market Facts
  • 2.2. Geographical Scenario
  • 2.3. Companies in the Market

3. NEUROPROSTHETICS KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. NEUROPROSTHETICS INDUSTRY STUDY

  • 4.1. Porter's Analysis
  • 4.2. Regulatory Framework Analysis
  • 4.3. Market Attractiveness Analysis
  • 4.4. Value Chain Analysis

5. NEUROPROSTHETICS MARKET LANDSCAPE

  • 5.1. Market Share Analysis

6. NEUROPROSTHETICS MARKET - BY TYPES:

  • 6.1. Overview
  • 6.2. Cochlear Implants
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.3. Motor Prosthetics
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.4. Cognitive Prosthetics
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.5. Retinal Implants
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

7. NEUROPROSTHETICS MARKET - BY TECHNOLOGY:

  • 7.1. Overview
  • 7.2. Vagus Nerve Stimulation
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.3. Spinal Cord Stimulation
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.4. Deep Brain Simulation
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.5. Sacral Nerve Stimulation
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

8. NEUROPROSTHETICS MARKET - BY TECHNOLOGY:

  • 8.1. Overview
  • 8.2. Physiological Disorders
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 8.2.3. Auditory Disorders
    • 8.2.3.1. Overview
    • 8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 8.2.4. Kidney Disorders
    • 8.2.4.1. Overview
    • 8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 8.2.5. Others
    • 8.2.5.1. Overview
    • 8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 8.3. Motor Neuron Disorders
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 8.3.3. Epilepsy
    • 8.3.3.1. Overview
    • 8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 8.3.4. Parkinson's disease
    • 8.3.4.1. Overview
    • 8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 8.4. Cognitive Disorders
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 8.4.3. Alzheimer's Disease
    • 8.4.3.1. Overview
    • 8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 8.4.4. Severe Depression
    • 8.4.4.1. Overview
    • 8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

9. NEUROPROSTHETICS MARKET- BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.2.3. U.S.
    • 9.2.3.1. Overview
    • 9.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.2.4. Canada
    • 9.2.4.1. Overview
    • 9.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.3.3. France
    • 9.3.3.1. Overview
    • 9.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.3.4. Germany
    • 9.3.4.1. Overview
    • 9.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.3.5. Rest of Europe
    • 9.3.5.1. Overview
    • 9.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.4.3. China
    • 9.4.3.1. Overview
    • 9.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.4.4. India
    • 9.4.4.1. Overview
    • 9.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.4.5. Rest of APAC
    • 9.4.5.1. Overview
    • 9.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.5. Rest of the World
    • 9.5.1. Overview
    • 9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.5.3. Latin America
    • 9.5.3.1. Overview
    • 9.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.5.4. Middle East and Africa
    • 9.5.4.1. Overview
    • 9.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Cochlear Limited
    • 10.1.1. Company Overview
    • 10.1.2. SWOT Analysis
    • 10.1.3. Key Developments
  • 10.2. St. Jude Medical, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. SWOT Analysis
    • 10.2.3. Key Developments
  • 10.3. Medtronic, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. SWOT Analysis
    • 10.3.3. Key Developments
  • 10.4. Nervo Corporation
    • 10.4.1. Company Overview
    • 10.4.2. SWOT Analysis
    • 10.4.3. Key Developments
  • 10.5. MED-EL
    • 10.5.1. Company Overview
    • 10.5.2. SWOT Analysis
    • 10.5.3. Key Developments

Client can request additional company profiling as per specific requirements

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. Abbreviations
  • 12.3. Disclaimer
  • 12.4. Contact Us

List of Tables

  • Table 1 List of Acronyms
  • Table 2 Key Market Facts, 2014 - 2025
  • Table 3 Market Drivers: Impact Analysis
  • Table 4 Market Restraint: Impact Analysis
  • Table 5 Market Opportunity: Impact Analysis
  • Table 6 PEST Analysis
  • Table 7 Porter's Five Forces Analysis
  • Table 8 Company Market Share Analysis
  • Table 9 Global Neuroprosthetics Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • Table 10 Neuroprosthetics Market, by Types, 2014 - 2025 (USD Million)
  • Table 11 Neuroprosthetics Market, by Technology, 2014 - 2025 (USD Million)
  • Table 12 Neuroprosthetics Market, by Application, 2014 - 2025 (USD Million)
  • Table 13 Neuroprosthetics Market, by Geography, 2014 - 2025 (USD Million)
  • Table 14 North America Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 15 U.S. Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 16 Canada Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 17 Europe Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 18 France Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 19 Germany Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 20 Asia Pacific Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 21 China Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 22 India Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 23 Latin America Neuroprosthetics Market, 2014 - 2025 (USD Million)
  • Table 24 MEA Neuroprosthetics Market, 2014 - 2025 (USD Million)

List of Figures

  • Figure 1 Research Methodology
  • Figure 2 Research Process Flow Chart
  • Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4 Regulatory Framework Analysis
  • Figure 5 Value Chain Analysis Analysis
  • Figure 6 Neuroprosthetics Market, by Types, 2014 - 2025 (USD Million)
  • Figure 7 Neuroprosthetics Market, by Technology, 2014 - 2025 (USD Million)
  • Figure 8 Neuroprosthetics Market, by Application, 2014 - 2025 (USD Million)
  • Figure 9 Neuroprosthetics Market, by Geography, 2014 - 2025 (USD Million)